Final Approval of $264 Million Settlement with Mylan Defendants Granted in EpiPen Class Action, Resulting in Total Recovery of $609 Million for the Class

July 11, 2022 – Judge Daniel D. Crabtree has granted final approval to the $264 million settlement between Plaintiffs and the Mylan Defendants in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, finding the settlement to …

Final Approval of $264 Million Settlement with Mylan Defendants Granted in EpiPen Class Action, Resulting in Total Recovery of $609 Million for the Class Read More »

Supreme Court Unanimously Rejects NCAA Limits on Education-Related Benefits, in Victory for Pritzker Levine Client and Other Student-Athletes

June 21, 2021 – In a ground-breaking, unanimous decision, the United States Supreme Court affirmed Northern District of California Judge Claudia Wilken’s determination following a bench trial that NCAA limits on education-related benefits were unreasonable restraints of trade under antitrust law and …

Supreme Court Unanimously Rejects NCAA Limits on Education-Related Benefits, in Victory for Pritzker Levine Client and Other Student-Athletes Read More »